Rivaroxaban has predictable pharmacokinetics (PK) and pharmacodynamics (PD) when given once or twice daily for the treatment of acute, proximal deep vein thrombosis (DVT) - Mueck, W; Agnelli, G; Buller, H (Blood, 2007)